The observation in our previous study of frequent IMPDH2 overexpression in osteosarcoma patients with poor response to chemotherapy and the identification of IMPDH2 as an independent prognostic marker for chemotherapy response suggest that IMPDH2 might be directly involved in the development of chemoresistance. Here, IMPDH2 is linked to osteosarcoma.